Bolt Biotherapeutics has announced the acquisition of fellow USA-based Prana Therapies, a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results